N0 (N=64) |
N1 (N=20) |
N2 (N=11) |
P-value | |
---|---|---|---|---|
pathologic_T | ||||
T3 | 64 (100%) | 20 (100%) | 11 (100%) | <0.001 |
pathologic_M | ||||
M0 | 44 (68.8%) | 14 (70.0%) | 8 (72.7%) | 0.0844 |
MX | 20 (31.3%) | 6 (30.0%) | 2 (18.2%) | |
M1 | 0 (0%) | 0 (0%) | 1 (9.1%) | |
pathologic_stage | ||||
Stage II | 62 (96.9%) | 0 (0%) | 0 (0%) | <0.001 |
Stage III | 0 (0%) | 20 (100%) | 10 (90.9%) | |
Stage IV | 0 (0%) | 0 (0%) | 1 (9.1%) | |
Missing | 2 (3.1%) | 0 (0%) | 0 (0%) | |
Age (years) | ||||
Mean (SD) | 66.3 (9.80) | 65.6 (8.70) | 63.3 (13.5) | 0.391 |
Median [Min, Max] | 69.0 [41.0, 84.0] | 67.0 [44.0, 77.0] | 68.5 [40.0, 79.0] | |
Missing | 1 (1.6%) | 1 (5.0%) | 1 (9.1%) | |
gender | ||||
FEMALE | 23 (35.9%) | 6 (30.0%) | 6 (54.5%) | 0.385 |
MALE | 41 (64.1%) | 14 (70.0%) | 5 (45.5%) |